Foot Injury Clinical Trial
Official title:
Comparing the Effectiveness of Computer-aided-design Computer-aided-manufacture (CAD/CAM) Insoles Manufactured From Foam-box Cast vs Direct Scan on Patient Reported Outcome Measures: A Double-blinded, Randomised Controlled Trial
Verified date | January 2024 |
Source | NHS Greater Glasgow and Clyde |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main purpose of this study is to find out if scanning the foot using a 3D scanner influences the effectiveness of custom made insoles, compared to the more traditional approach of taking a foam-box impression cast of the foot. Both of these methods are currently used as standard care in the NHS Greater Glasgow and Clyde (GGC) Orthotic Department. In this study, insoles will be manufactured either from a direct 3D scan of the foot, or from a foam-box impression cast, and a series of questionnaires will be used to measure any changes in foot pain and foot function. The results from this study will be used to develop an information resource for both patients and Orthotists which will fill gaps in our current knowledge and hopefully guide us further in providing the best possible care for future patients who require insoles.
Status | Completed |
Enrollment | 114 |
Est. completion date | November 24, 2023 |
Est. primary completion date | November 24, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Are aged 18 years or above - Are referred to the NHS GGC Orthotic service requiring a new assessment for insoles - are deemed suitable for CAD/CAM insoles as assessed by the PI or Co-I on clinical assessment - Are able to commit to five appointments over a 16-week period (two Face-to-Face appointments, three Telephone Appointments) - Have suitable own footwear that can accommodate a CAD/CAM insole as assessed by the PI or Co-I, and as per standard practice can wear these for 12-weeks - Is willing to allow their General Practitioner and consultant, if appropriate, to be notified of participation in the trial. - An adequate understanding of written and verbal information in English in order to provide informed consent and answer the study questionnaires Exclusion Criteria: - Scheduled elective surgery or other procedures which is likely to affect mobility during the trial. - Scheduled steroid injection of the foot or ankle up to 3 months prior to joining the trial, or during participation in the trial - Age <18 years - Adult with Incapacity, under The Adults with Incapacity (Scotland) Act 2000 - Participant unable or unwilling to consent - Medial longitudinal Arch height of the foot exceeds depth of EVA blank (35mm) - Clinical assessment concludes that the participant requires an insole material other than EVA - Clinical assessment concludes that the participant does not require or will be unlikely to benefit from CAD/CAM insoles. - The participant is unable to commit to the trial conditions. - Peripheral Neuropathy present - Active foot ulceration present - Participant with life expectancy of less than 6 months. - Any other significant disease or disorder which, in the opinion of the PI or Co-I, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial. - Participants who have participated in another research trial involving an investigational foot orthosis in the past 12 weeks. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Orthotics Department, Glasgow Royal Infirmary | Glasgow |
Lead Sponsor | Collaborator |
---|---|
NHS Greater Glasgow and Clyde | University of Central Lancashire |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Tertiary outcome measure - Recruitment rate | Recruitment rate = n/recruitment period | Measured from the date of 1st participant being recruited, until recruitment completed. Anticipated 9 months. | |
Other | Tertiary outcome measure - Participant compliance with the study protocol / Adherence | Patients will keep a diary of daily wear time in hours, in accordance with prior publications on measuring Orthotic Adherence. The minimum threshold for adherence is >21 hours per week | Measured from the date of 1st participant being recruited, until trial completed. Anticipated 12 months. | |
Other | Tertiary outcome measure - Dropout rate | Dropout rate = n dropout/duration of trial | Measured from the date of 1st participant being recruited, until trial completed. Anticipated 12 months. | |
Primary | Foot Health Status Questionnaire (FHSQ) - Pain sub-domain | To compare the changes in pain in two groups of participants fitted with custom CAD/CAM insoles manufactured using different foot shape capture methods | Measured 4 times throughout the 12-week period that the participant is wearing the insoles: Baseline immediately after receiving intervention (insoles). 4 weeks after intervention. 8 weeks after intervention. And 12 weeks after intervention | |
Secondary | Foot Health Status Questionnaire (FHSQ) - Function sub-domain | To compare the changes in foot function in two groups of participants fitted with custom CAD/CAM insoles manufactured using different foot shape capture methods | Measured 4 times throughout the 12-week period that the participant is wearing the insoles: Baseline immediately after receiving intervention (insoles). 4 weeks after intervention. 8 weeks after intervention. And 12 weeks after intervention | |
Secondary | Foot Health Status Questionnaire - foot health sub-domain | To compare the changes in foot health in two groups of participants fitted with custom CAD/CAM insoles manufactured using different foot shape capture methods | Measured 4 times throughout the 12-week period that the participant is wearing the insoles: Baseline immediately after receiving intervention (insoles). 4 weeks after intervention. 8 weeks after intervention. And 12 weeks after intervention | |
Secondary | Orthotic and Prosthetic User Survey9-12 (Satisfaction with device survey) | To compare the patient satisfaction in two groups of participants fitted with custom CAD/CAM insoles manufactured using different foot shape capture methods | Measured 12 weeks after being fitted with insoles | |
Secondary | time-in-transit | Measurement of transit times associated with each arm of the trial will be compared. This will be measured in days. Measuring the number of days for each insole to be delivered after foot shape capture. | Measured for each participant, from the day of foot-shape-capture to the time of insoles being delivered to the Glasgow Royal Infirmary, up to 42 days. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05555459 -
Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation
|
N/A | |
Completed |
NCT06086418 -
Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery
|
Phase 4 | |
Not yet recruiting |
NCT05762588 -
JuggerKnot With Broadband PMCF Study
|
||
Terminated |
NCT02953067 -
Study of Treatment of Lisfranc Injuries
|
N/A | |
Not yet recruiting |
NCT06352788 -
From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices
|
N/A | |
Completed |
NCT02645097 -
Ideal Anatomic Location for Saphenous Nerve Blocks: A Prospective Clinical Evaluation
|
N/A | |
Completed |
NCT05190159 -
Monster Screw System Post-Market Clinical Follow-Up Study
|
||
Recruiting |
NCT06242002 -
Early Post-operative Monitoring by Sensor of Patients Undergoing Forefoot Surgery
|
N/A | |
Active, not recruiting |
NCT04967040 -
Reconstruction of Ankle and Foot Defects
|
N/A | |
Terminated |
NCT02643524 -
Weight Change With Controlled Ankle Movement (CAM) Walker Boot Use
|
N/A | |
Recruiting |
NCT06300671 -
The Effect of Subtalar Joint Pronation Amount on Lower Extremity Alignment and Performance
|
N/A | |
Completed |
NCT05323773 -
How is Calf Muscle Endurance Related to Ankle Injuries in TeamGym Athletes?
|
||
Not yet recruiting |
NCT06304324 -
Dexmedetomidine vs Dexamethasone in Popliteal Nerve Block
|
Phase 4 | |
Completed |
NCT05090059 -
Myofascial Points Treatment With Focused Extracorporeal Shock Waves (ESW)
|
N/A |